Sintilimab: another effective immune checkpoint inhibitor in classical Hodgkin lymphoma

被引：9
|
作者：
Ansell, Stephen M. [1 ]
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN 55905 USA
来源：
LANCET HAEMATOLOGY | 2019年 / 6卷 / 01期
关键词：
CELL TRANSPLANTATION; BRENTUXIMAB VEDOTIN; PHASE-II; NIVOLUMAB; PEMBROLIZUMAB; MULTICOHORT; BLOCKADE; FAILURE;
D O I：
10.1016/S2352-3026(18)30210-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E2 / E3
页数：2
相关论文
共 50 条
  • [21] Checkpoint Inhibitors and Other Immune Therapies for Hodgkin and Non-Hodgkin Lymphoma
    Eri Matsuki
    Anas Younes
    Current Treatment Options in Oncology, 2016, 17
  • [22] Checkpoint Inhibitors and Other Immune Therapies for Hodgkin and Non-Hodgkin Lymphoma
    Matsuki, Eri
    Younes, Anas
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (06)
  • [23] Predictive cytokine biomarkers for immune-related adverse events associated with immune checkpoint inhibitor therapy in Hodgkin lymphoma
    Luke, Neeti
    Pratt, Maria
    Gong, Judy
    Borghi, Sara
    Diefenbach, Catherine S.
    Hillier, Kirsty
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [24] Complex Immune Evasion Strategies in Classical Hodgkin Lymphoma
    Wein, Frederik
    Weniger, Marc A.
    Hoeing, Benedikt
    Arnolds, Judith
    Huettmann, Andreas
    Hansmann, Martin-Leo
    Hartmann, Sylvia
    Kueppers, Ralf
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (12) : 1122 - 1132
  • [25] Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphoma
    Li, Wenchao
    Blessin, Niclas C.
    Simon, Ronald
    Kluth, Martina
    Fischer, Kristine
    Hube-Magg, Claudia
    Makrypidi-Fraune, Georgia
    Wellge, Bjoern
    Mandelkow, Tim
    Debatin, Nicolaus F.
    Pott, Laura
    Hoeflmayer, Doris
    Lennartz, Maximilian
    Sauter, Guido
    Izbicki, Jakob R.
    Minner, Sarah
    Buescheck, Franziska
    Uhlig, Ria
    Dum, David
    Krech, Till
    Luebke, Andreas M.
    Wittmer, Corinna
    Jacobsen, Frank
    Burandt, Eike
    Steurer, Stefan
    Wilczak, Waldemar
    Hinsch, Andrea
    BMC CANCER, 2018, 18
  • [26] Expression of the immune checkpoint receptor TIGIT in Hodgkin’s lymphoma
    Wenchao Li
    Niclas C. Blessin
    Ronald Simon
    Martina Kluth
    Kristine Fischer
    Claudia Hube-Magg
    Georgia Makrypidi-Fraune
    Björn Wellge
    Tim Mandelkow
    Nicolaus F. Debatin
    Laura Pott
    Doris Höflmayer
    Maximilian Lennartz
    Guido Sauter
    Jakob R. Izbicki
    Sarah Minner
    Franziska Büscheck
    Ria Uhlig
    David Dum
    Till Krech
    Andreas M. Luebke
    Corinna Wittmer
    Frank Jacobsen
    Eike Burandt
    Stefan Steurer
    Waldemar Wilczak
    Andrea Hinsch
    BMC Cancer, 18
  • [27] The role of immune checkpoint inhibitors in allogeneic stem cell transplantation for patients with relapsed/refractory classical hodgkin lymphoma
    Afanasyev, Boris
    Beynarovich, Anastasiya
    Mikhailova, Natalia
    Lepik, Kirill
    Kondakova, Elena
    Borzenkova, Evgenia
    Kozlov, Andrey
    Zalyalov, Juri
    Stelmakh, Lilia
    Darskaya, Elena
    Moiseev, Ivan
    BONE MARROW TRANSPLANTATION, 2019, 54 : 458 - 458
  • [28] Kinetics and nadir of responses to immune checkpoint blockade by anti-PD1 in patients with classical Hodgkin lymphoma
    Dercle, Laurent
    Ammari, Samy
    Seban, Romain-David
    Schwartz, Lawrence H.
    Houot, Roch
    Labaied, Nizar
    Mokrane, Fatima-Zohra
    Lazarovici, Julien
    Danu, Alina
    Marabelle, Aurelien
    Ribrag, Vincent
    Michot, Jean-Marie
    EUROPEAN JOURNAL OF CANCER, 2018, 91 : 136 - 144
  • [29] Engraftment Syndrome Incidence after Immune Checkpoint Inhibitor Therapy in Pts with Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation: A Single Institutional Review
    Odetola, Oluwatobi
    Adekola, Kehinde
    Moreira, Jonathan
    Karmali, Reem
    Ma, Shuo
    Carson, Kenneth R.
    Mehta, Jayesh
    Winter, Jane N.
    Gordon, Leo I.
    Lin, Adam Yuh
    BLOOD, 2023, 142
  • [30] Pneumocystis Pneumonia Mimicking Immune Checkpoint Inhibitor-induced Pneumonitis in a Patient With Recurrent Hodgkin's Lymphoma
    Rizly, S.
    Labe, B.
    Rafiaa, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
12345